What is LOPJLB’s current signal on HALO?

LOPJLB’s latest quantitative signal on Halozyme Therapeutics, Inc. (HALO) is BUY in a BULL regime. Signals are updated daily.

What market regime is HALO in?

Halozyme Therapeutics, Inc. (HALO) is currently classified in the BULL HMM market regime on LOPJLB.

Halozyme Therapeutics, Inc. (HALO)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$111.08+0.60%Close

BUYBULL · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $13.2B
Beta: 0.88
P/E (TTM): 31.17

Short % float: 13.05%
Days to cover: 4.5
SI change: +0.9%

1W: +2.56%
1M: +3.62%

vs SPY 1W: +2.14%
vs SPY 1M: +1.56%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform,…

Employees: 423
Headquarters: US
Founded: 2004
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 118.6M
Float: 98.8%

halozyme.com ↗

Key executives

Helen I. Torley — President, Chief Executive Officer & Director

Darren Snellgrove — Senior Vice President & Chief Financial Officer

Mark Snyder — Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary

SEC filings

EDGAR · CIK 11590360 · HALO

Analyst consensus

Buy

Bullish1866.7%

Neutral829.6%

Bearish13.7%

L $90.00Avg $106.00H $130.00

Target$106.00-4.57%

Last$111.08

FAQ

What is LOPJLB’s current signal on HALO?: LOPJLB’s latest quantitative signal on Halozyme Therapeutics, Inc. (HALO) is BUY in a BULL regime. Signals are updated daily.
What market regime is HALO in?: Halozyme Therapeutics, Inc. (HALO) is currently classified in the BULL HMM market regime on LOPJLB.
What does Halozyme Therapeutics, Inc. (HALO) do?: Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform, which utilizes a patented recombinant human hyaluronidase enzyme (rHuPH20). This innovative technology significantly enh…

Key stats

Industry peers

Prediction markets

Company news

FAQ